Literature DB >> 28973299

Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.

Michelle C Miller1, Y Zheng2, Jingmin Yan2, Yifa Zhou2, Guihua Tai2, Kevin H Mayo1.   

Abstract

Interactions between galectins and polysaccharides are crucial to many biological processes, and yet these are some of the least understood, usually being limited to studies with small saccharides and short oligosaccharides. The present study is focused on human galectin-3 (Gal-3) interactions with a 60 kDa rhamnogalacturonan RG-I-4 that we use as a model to garner information as to how galectins interact with large polysaccharides, as well as to develop this agent as a therapeutic against human disease. Gal-3 is unique among galectins, because as the only chimera-type, it has a long N-terminal tail (NT) that has long puzzled investigators due to its dynamic, disordered nature and presence of numerous prolines. Here, we use 15N-1H heteronuclear single quantum coherence NMR spectroscopy to demonstrate that multiple sites on RG-I-4 provide epitopes for binding to three sites on 15N-labeled Gal-3, two within its carbohydrate recognition domain (CRD) and one at a novel site within the NT encompassing the first 40 residues that are highly conserved among all species of Gal-3. Moreover, strong binding of RG-I-4 to the Gal-3 NT occurs on a very slow time scale, suggesting that it may be mediated by cis-trans proline isomerization, a well-recognized modulator of many biological activities. The NT binding epitope within RG-I-4 appears to reside primarily in the side chains of the polysaccharide, some of which are galactans. Our results provide new insight into the role of the NT in Gal-3 function.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  galectin; polysaccharide

Mesh:

Substances:

Year:  2017        PMID: 28973299      PMCID: PMC5881736          DOI: 10.1093/glycob/cwx071

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  52 in total

1.  The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship.

Authors:  Xiaoge Gao; Yuan Zhi; Lin Sun; Xiaoxia Peng; Tao Zhang; Huiting Xue; Guihua Tai; Yifa Zhou
Journal:  J Biol Chem       Date:  2013-10-07       Impact factor: 5.157

2.  New method for quantitative determination of uronic acids.

Authors:  N Blumenkrantz; G Asboe-Hansen
Journal:  Anal Biochem       Date:  1973-08       Impact factor: 3.365

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 4.  Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Authors:  Gerburg Wulf; Greg Finn; Futoshi Suizu; Kun Ping Lu
Journal:  Nat Cell Biol       Date:  2005-05       Impact factor: 28.824

5.  Prolyl isomerization as a molecular timer in phage infection.

Authors:  Barbara Eckert; Andreas Martin; Jochen Balbach; Franz X Schmid
Journal:  Nat Struct Mol Biol       Date:  2005-06-05       Impact factor: 15.369

6.  Structural aspects of binding of α-linked digalactosides to human galectin-1.

Authors:  Michelle C Miller; João P Ribeiro; Virginia Roldós; Sonsoles Martín-Santamaría; F Javier Cañada; Irina A Nesmelova; Sabine André; Mabel Pang; Anatole A Klyosov; Linda G Baum; Jesús Jiménez-Barbero; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Glycobiology       Date:  2011-06-28       Impact factor: 4.313

Review 7.  A case study of proline isomerization in cell signaling.

Authors:  Lie Min; D Bruce Fulton; Amy H Andreotti
Journal:  Front Biosci       Date:  2005-01-01

8.  A native to amyloidogenic transition regulated by a backbone trigger.

Authors:  Catherine M Eakin; Andrea J Berman; Andrew D Miranker
Journal:  Nat Struct Mol Biol       Date:  2006-02-19       Impact factor: 15.369

Review 9.  Modified citrus pectin anti-metastatic properties: one bullet, multiple targets.

Authors:  Vladislav V Glinsky; Avraham Raz
Journal:  Carbohydr Res       Date:  2008-09-26       Impact factor: 2.104

10.  The two endocytic pathways mediated by the carbohydrate recognition domain and regulated by the collagen-like domain of galectin-3 in vascular endothelial cells.

Authors:  Xiaoge Gao; Dan Liu; Yuying Fan; Xinzhi Li; Huiting Xue; Yingyun Ma; Yifa Zhou; Guihua Tai
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more
  6 in total

1.  The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan.

Authors:  Jerzy Maksymowicz; Anna Palko-Łabuz; Beata Sobieszczańska; Mateusz Chmielarz; Mirosława Ferens-Sieczkowska; Magdalena Skonieczna; Agnieszka Wikiera; Olga Wesołowska; Kamila Środa-Pomianek
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-09

Review 2.  Messenger RNA Life-Cycle in Cancer Cells: Emerging Role of Conventional and Non-Conventional RNA-Binding Proteins?

Authors:  Lucie Coppin; Julie Leclerc; Audrey Vincent; Nicole Porchet; Pascal Pigny
Journal:  Int J Mol Sci       Date:  2018-02-25       Impact factor: 5.923

Review 3.  Galectins as Molecular Targets for Therapeutic Intervention.

Authors:  Ruud P M Dings; Michelle C Miller; Robert J Griffin; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

4.  Novel Dextran-Supported Biological Probes Decorated with Disaccharide Entities for Investigating the Carbohydrate-Protein Interactions of Gal-3.

Authors:  Jani Rahkila; Filip S Ekholm; Ana Ardá; Sandra Delgado; Johannes Savolainen; Jesús Jiménez-Barbero; Reko Leino
Journal:  Chembiochem       Date:  2018-11-30       Impact factor: 3.164

Review 5.  Galectins as Checkpoints of the Immune System in Cancers, Their Clinical Relevance, and Implication in Clinical Trials.

Authors:  Daniel Compagno; Carolina Tiraboschi; José Daniel Garcia; Yorfer Rondón; Enrique Corapi; Carla Velazquez; Diego José Laderach
Journal:  Biomolecules       Date:  2020-05-12

Review 6.  The Complex Biological Effects of Pectin: Galectin-3 Targeting as Potential Human Health Improvement?

Authors:  Lucas de Freitas Pedrosa; Avraham Raz; João Paulo Fabi
Journal:  Biomolecules       Date:  2022-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.